[Doctor, is my mother suffering from dementia?]

Area of Science:

• Neurology
• Geriatrics
• Public Health

Background:

• The Netherlands utilizes a structured, stepwise diagnostic pathway for dementia care.
• This pathway encompasses primary, secondary, and tertiary care levels.
• Established guidelines, including the NHG practice guideline 'Dementia', inform the diagnostic process.

Purpose of the Study:

• To describe the dementia diagnostic process within the Dutch healthcare system.
• To highlight newly available validated instruments for dementia diagnostics.
• To explain how individual dementia risk can be estimated.

Main Methods:

• The study outlines the patient's journey through primary care (general practitioner), secondary care (memory clinics), and tertiary care (academic Alzheimer centers).
• It references the 'Dementia' care practice guideline and the multidisciplinary guideline 'Dementia diagnostics'.
• It mentions the use of validated instruments such as the Amsterdam instrumental activities of daily living (A-IADL) scale, cerebrospinal fluid (CSF) biomarkers, and the Medial temporal atrophy (MTA) scale for MRI interpretation.

Main Results:

• Most patients receive an adequate diagnosis and appropriate care after utilizing only a portion of the described care chain.
• New validated diagnostic tools, including the A-IADL scale, CSF biomarkers, and MTA scale for MRI, are now available.
• Dementia risk can be estimated using Mini-Mental State Examination (MMSE) scores, MRI scans, and CSF investigation results.

Conclusions:

• The Dutch healthcare system provides a comprehensive yet adaptable pathway for dementia diagnosis.
• The integration of new validated instruments enhances the accuracy and efficiency of dementia diagnostics.
• Objective measures like MMSE, MRI, and CSF analysis contribute to personalized dementia risk assessment.